Bullous pemphigoid evolving into cicatricial pemphigoid?

Clinical and Experimental Dermatology

Volumn 22, Issue 1, 1997, Pages 30-33

  Banfield, C C ^a   Papadavid, E ^a   Frith, P ^b   Allen, J ^a   Wojnarowska, F T ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CLOBETASOL PROPIONATE; DAPSONE; MINOCYCLINE; NICOTINAMIDE; OXYTETRACYCLINE; PREDNISOLONE;

ADULT; AGED; ALLELE; ANTIBODY TITER; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HLA SYSTEM; HUMAN; IMMUNOBLOTTING; IMMUNOGENETICS; MUCOUS MEMBRANE PEMPHIGOID; PEMPHIGOID; PRIORITY JOURNAL;

EID: 0030816503     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.1997.d01-234.x     Document Type: Article

References (13)

1. Frith P, Venning V, Wojnarowska F et al. Conjunctival involvement in cicatricial and bullous pemphigoid: a clinical and immunopathological study. Br J Ophthalmol 1989; 73: 52-6.
2. Venning V, Frith P, Bron A et al. Mucosal involvement in bullous and cicatricial pemphigoid. A clinical and immunopathological study. Br J Dermatol 1988; 118: 7-15.
3. George S, Venning V, Allen J et al. Bullous pemphigoid is strongly associated with HLA-DQ7 in males. J Invest Dermatol 1993; 101: 481 (Abstr.).
4. Yunis J, Mobini N, Yunis E et al. Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid. Proc Natl Acad Sci USA 1994; 91: 7747-51.
5. Mallon E, Wakelin S, Setterfield J et al. Increased frequency of HLA DQ7 in male and female patients with cicatricial pemphigoid. Br J Dermatol 1995; 45: 42 (Abstr.).
6. Muller S, Klaus-Kovtun V, Stanley J. A 230-kD basic protein is the major bullous pemphigoid antigen. J Invest Dermatol 1989; 92: 33-8.
7. Labib R, Anhalt G, Patel H et al. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol 1986; 136: 1231-5.
8. Bernard P, Prost C, Lecerf V et al. Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis. J Invest Dermatol 1990; 94: 630-5.
9. Bernard P, Prost C, Durepaire N et al. The major cicatricial pemphigoid antigen is a 180 kDa protein that shows immunologic cross reactivities with the bullous pemphigoid antigen. J Invest Dermatol 1992; 99: 174-9.
10. Liu Z, Diaz L, Troy J et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen BP180. J Clin Invest 1993; 92: 2480-8.
11. Fine J, Neises G, Katz S. Immunofluorescence and immunoelectron microscopic studies in cicatricial pemphigoid. J Invest Dermatol 1984; 82: 39-43.
12. Horiguchi Y, Tanaka T, Akioka N et al. Restriction of cicatricial pemphigoid antigens to the lamina densa: confirmation by indirect immunoelectron microscopy. J Dermatol 1992; 19: 449-55.
13. Poskitt L, Wojnarowska F. Minimizing cicatricial pemphigoid orodynia with minocycline. Br J Dermatol 1995; 132: 784-9.